Sabaa International Company for Pharmaceutical and Chemical Industry (EGX: SIPC)

EGX: SIPC Cash Flow Statement

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-8.58	0.14	0.02	6.78	15.14	8.59
Depreciation & Amortization	2.54	2.88	3.82	3.64	2.38	1.96
Other Amortization	0.58	0.35	0.39	1.13	5.18	4.99
Provision & Write-off of Bad Debts	-0.01	-0.04	-	-	0.25	-
Other Operating Activities	9.73	0.87	0.38	-0.16	-0.16	2
Change in Accounts Receivable	-3.28	4.27	-2.66	-1.83	16.14	-6.42
Change in Inventory	-1.8	-18.35	-3.46	4.23	-5	0.37
Change in Accounts Payable	8.58	11.65	-0.33	-1.13	1.01	1.61
Change in Other Net Operating Assets	2.86	-0.2	6.56	6.96	-0.19	-
Operating Cash Flow	10.63	1.55	4.72	19.61	34.75	13.1
Operating Cash Flow Growth	-	-67.04%	-75.95%	-43.55%	165.31%	118.87%
Capital Expenditures	-2.12	-1.09	-22	-16.18	-50	-14.59
Other Investing Activities	-0.23	-0.23	16.13	-0.38	1.21	-1.44
Investing Cash Flow	-2.39	-1.32	-5.88	-16.56	-48.79	-16.02
Long-Term Debt Issued	-	-	0.1	-	9.4	1.5
Long-Term Debt Repaid	-	-	-	-1.9	-	-
Net Debt Issued (Repaid)	-0.5	-	0.1	-1.9	9.4	1.5
Common Dividends Paid	-	-	-0.61	-1.59	-0.77	-0.15
Other Financing Activities	-	-	-	-	-	0.46
Financing Cash Flow	-0.5	-	-0.51	-3.49	8.62	1.8
Foreign Exchange Rate Adjustments	-8.08	-0	0	-	-	-
Net Cash Flow	-0.34	0.24	-1.67	-0.43	-5.42	-1.13
Free Cash Flow	8.51	0.47	-17.29	3.44	-15.25	-1.49
Free Cash Flow Margin	54.69%	3.50%	-94.98%	7.57%	-21.86%	-2.21%
Free Cash Flow Per Share	0.03	0.00	-0.07	0.01	-	-0.00
Cash Income Tax Paid	0.3	0.13	0.67	2.27	4.58	0.5
Levered Free Cash Flow	1.35	-0.01	-17.33	1.14	-18.87	-2.52
Unlevered Free Cash Flow	2.21	0.84	-16.67	1.55	-18.46	-1.47
Change in Net Working Capital	-1.88	2.56	-0.14	-7.43	-11.34	1.81

Source: S&P Capital IQ. Standard template. Financial Sources.